Pharmally sweetheart deal warrants probe
Congressmen said the Senate blue ribbon committee’s investigation of the transfer of COVID-19 funds from the Department of Health to the Department of Budget and Management is meant to destroy the President.
Far from it. The President himself said he requested Michael Yang, a Chinese national and a long-time Davao businessman, to help Pharmally Pharmaceutical Corp., a newly organized trading company with a capital of only P625,000 and with no track record. The award of the P8.7 billion contract to Pharmally is a sweetheart deal. One who has P42 billion will not even think of talking to a new entity with only P625,000 capital, no declared income, and no track record.
The award to Pharmally is grossly disadvantageous to the government; it calls for a thorough investigation for violation of the Anti-Graft and Corrupt Practices Act.
Article continues after this advertisementIn a similar situation, Malacañang would say: “If they have nothing to hide, they should let the hearings continue.”
Jose J. Ferrer, Jr., jjferrerjr1@yahoo.com
For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.
